Atlas Trials

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Clinical trial NCT04421456 · TERMINATED

Trial details

NCT number
NCT04421456
Sponsor
Jazz Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2020-08-18
Primary completion
2022-03-16
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.